Preprint · OA
via OpenAlex
Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
A Furuta, Donald L. Price, Carlos A. Pardo, J. C. Troncoso, Zuoshang Xu, Naoyuki Taniguchi, Lee J. Martin
PubMed · 1995 · ▲ 150 citations
Abstract
Abnormalities in the cellular regulation and expression of antioxidant enzymes may have a role in mechanisms of central nervous system aging and neurodegeneration. We therefore examined, using isozyme-specific antibodies and immunohistochemistry, the localization of copper, zinc-superoxide dismutase and manganese-superoxide dismutase in the frontal and temporal neocortices and hippocampi of aged controls and individuals with Alzheimer's disease or Down's syndrome. Two different antibodies to copper, zinc-superoxide dismutase and one antibody to manganese-superoxide dismutase were evaluated by immunoblotting of homogenates of human brain before use in immunohistochemistry. The copper, zinc-superoxide dismutase antibodies recognized a single band of proteins at 16 kd. The manganese-superoxide dismutase antibody detected a single band of proteins at 25 kd. Immunohistochemically, copper, zinc-superoxide dismutase and manganese-superoxide dismutase immunoreactivities were localized predominantly to neocortical and hippocampal pyramidal neurons and scarcely seen in glial cells in controls. In Alzheimer's disease and Down's syndrome, the distributions and intensities of these two forms of superoxide dismutase immunoreactivities were different as compared with controls. Copper, zinc-superoxide dismutase was enriched in pyramidal neurons undergoing degeneration, whereas manganese-superoxide dismutase was more enriched in reactive astrocytes than in neurons. In senile plaques, copper, zinc-superoxide dismutase-positive globular structures were surrounded by astrocytes highly enriched in manganese-superoxide dismutase. By double label immunohistochemistry, some pyramidal neurons coexpressed superoxide dismutases and tau, and a few copper, zinc-superoxide dismutase-positive structures in senile plaques colocalized with tau. Amyloid cores, diffuse plaques, and microglia scarcely showed colocalization with superoxide dismutase-positive structures. The observed changes in the cellular localization of superoxide dismutases in neocortex and hippocampus in cases of Alzheimer's disease and Down's syndrome support a role for oxidative injury in neuronal degeneration and senile plaque formation. The differential localization of copper, zinc-superoxide dismutase and manganese-superoxide dismutase in cerebral sites of degeneration suggests that cellular responses to oxidative stress is antioxidant enzyme specific and cell type specific and that these two forms of superoxide dismutase may have different functions in antioxidant mechanisms.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Furuta, A., Price, D.L., Pardo, C.A., Troncoso, J.C., Xu, Z., Taniguchi, N., & Martin, L.J. (1995). Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. <em>PubMed</em>. https://openalex.org/W2179896419
Vancouver
Furuta A, Price DL, Pardo CA, Troncoso JC, Xu Z, Taniguchi N, et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. PubMed. 1995.
BibTeX
@unpublished{a1995Locali,
title = {Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.},
author = {A Furuta and Donald L. Price and Carlos A. Pardo and J. C. Troncoso and Zuoshang Xu and Naoyuki Taniguchi and Lee J. Martin},
journal = {PubMed},
year = {1995},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University Hospital, Basel, Switzerland 2008
Open access · US-GOV
Systematic Characterization of the Cellular Proteome From Human Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease
Biomedicines 2026
Open access · OA
Genetic Determinants of Telomere Length and Their Role in Human Disease: Molecular Mechanisms and Underrepresented Populations’ Perspectives
Molecular Neurodegeneration 2025
Open access · CC-BY
The UNC5C T835M mutation associated with Alzheimer’s disease leads to neurodegeneration involving oxidative stress and hippocampal atrophy in aged mice
Brain 2010
Open access · OA
Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy
Cell and Tissue Research 2021
Open access · CC-BY
Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2023
Open access · US-GOV